Arbutus Biopharma Corp ABUS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 08/12/22 EDT
2.50UNCH (UNCH)
Volume
9,598
Close
2.50quote price arrow up+0.03 (+1.21%)
Volume
704,120
52 week range
1.93 - 6.50
Loading...
  • Open2.46
  • Day High2.54
  • Day Low2.45
  • Prev Close2.50
  • 52 Week High6.50
  • 52 Week High Date12/01/21
  • 52 Week Low1.93
  • 52 Week Low Date05/10/22

Key Stats

  • Market Cap374.87M
  • Shares Out149.95M
  • 10 Day Average Volume1.10M
  • Dividend-
  • Dividend Yield-
  • Beta2.25
  • YTD % Change-35.73

KEY STATS

  • Open2.46
  • Day High2.54
  • Day Low2.45
  • Prev Close2.50
  • 52 Week High6.50
  • 52 Week High Date12/01/21
  • 52 Week Low1.93
  • 52 Week Low Date05/10/22
  • Market Cap374.87M
  • Shares Out149.95M
  • 10 Day Average Volume1.10M
  • Dividend-
  • Dividend Yield-
  • Beta2.25
  • YTD % Change-35.73

RATIOS/PROFITABILITY

  • EPS (TTM)-0.61
  • P/E (TTM)-4.13
  • Fwd P/E (NTM)-4.57
  • EBITDA (TTM)-62.589M
  • ROE (TTM)-155.17%
  • Revenue (TTM)33.37M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-211.09%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/02/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Arbutus Biopharma Corp

There is no recent news for this security.

Profile

MORE
Arbutus Biopharma Corporation is a clinical-stage, biopharmaceutical company. The Company is focused on virology capabilities to develop therapeutics that target specific viral diseases. The Company’s focus areas include Hepatitis B virus (HBV), SARS-CoV-2 and other coronaviruses. In HBV, the Company is developing a ribonucleic acid interference (RNAi) therapeutic, oral capsid inhibitor, an oral PD-L1 inhibitor, and oral RNA destabilizer that it intends to combine to provide...
Frank Torti M.D.
Independent Chairman of the Board
William Collier
President, Chief Executive Officer, Director
David Hastings
Chief Financial Officer
Elizabeth Howard J.D., Ph.D.
Executive Vice President, General Counsel, Chief Compliance Officer and Secretary
Address
701 Veterans Circle
Warminster, PA
18974
United States

Top Peers

SYMBOLLASTCHG%CHG
TH
Target Hospitality Corp
13.63+0.91+7.15%
CYBN
Cybin Inc
0.80-0.0566-6.6075%
MBX
PRTG
Portage Biotech Inc
7.71-0.28-3.50%
CRDL
Cardiol Therapeutics Inc
1.25+0.09+7.76%